Wednesday 18 June 2025
  • About
  • Contact
  • Login
  • VC & Investment
  • M&A
  • AI
  • Podcasts
  • News
    • Pharmaceutical News
    • Biotechnology News
    • Generics News
    • Biosimilars news
    • In Brief
    • Legal
    • Company Pages
    • In The Boardroom
  • Insights
    • Analysis
    • Special Report
    • Interviews
    • Expert View
    • From Our Correspondent
    • One To Watch Companies
    • Digital Pharma
    • Pharma Leaders
  • Regulatory
    • FDA
    • EMA
    • Pricing, Reimbursement and Access
    • Regulation
    • Government Affairs
    • Biden Administration
  • Therapy Areas
    • Dermatologicals
    • Oncology
    • Neurological
    • Rare Diseases
    • Hematology
    • Cardio Vascular
    • Diabetes
    • Cell And Gene Therapy
  • Conferences
    • JPM Healthcare Conference
    • ESMO
    • ASCO
    • ASH
    • EULAR
    • AAIC
    • EASD
    • Forthcoming Events
  • Ones to Watch
  • About
  • Contact
  • Newsletter
  • Sign inSubscribe
Subscribe

Subscribe to our newsletters

The Pharma Letter offers free daily, weekly and monthly email alerts, providing a broad range of news insights and industry analysis direct to your inbox.

While the Daily Newsletter offers a roundup of all the headlines from the last 24 hours, the Weekly Roundup gives you our Editor's key insights into the leading pharma and biotech stories.

On a monthly basis, you can also stay abreast of key executive appointments with the Boardroom Bulletin, monitor emerging and rising biotech stars with the Start-ups and Scale ups Bulletin and keep an eye on all the dealmaking news with the M&A Bulletin.


Sign up to receive email updates

* indicates required
Newsletters

Today's issue

Advanced therapies campus to help turn Saudi into global biotech hub
Biotechnology
Advanced therapies campus to help turn Saudi into global biotech hub
17 June 2025
Generics
Medicines for Europe outlines trade policy recommendations
17 June 2025
Pharmaceutical
Hopes to add to Venclexta/Venclyxto label dashed
17 June 2025
Pharmaceutical
$7.4 billion Purdue settlement agreed with US states
17 June 2025
Biotechnology
Lilly to acquire Verve Therapeutics
17 June 2025
Biotechnology
FDA nod for CSL’s Andembry adds to HAE treatment landscape
17 June 2025
Biotechnology
D&D Pharmatech touts positive Phase II results for DD01 in MASH
17 June 2025

Company Spotlight

A biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes.

Latest Features

Biotechnology
Advanced therapies campus to help turn Saudi into global biotech hub
17 June 2025
Generics
Medicines for Europe outlines trade policy recommendations
17 June 2025
Pharmaceutical
Hopes to add to Venclexta/Venclyxto label dashed
17 June 2025
Pharmaceutical
$7.4 billion Purdue settlement agreed with US states
17 June 2025

The Pharma Letter

39-43 Putney High Street, Putney
London, SW15 1SP
United Kingdom

  • About us
  • Contact
  • Subscribe
  • Sponsorship/advertising


  • Terms and Conditions
  • Privacy Policy
  • Twitter
  • Linkedin

Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze